Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 1351 - 1375 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▲ Formula
Diacylglycerophosphoinositolglycans LMGP15010149
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(16:0/16:2(9Z,12Z))
126457517 1454.705833 C65H115O33P
Diacylglycerophosphoinositolglycans LMGP15010170
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(18:2(9Z,12Z)/14:0)
126457538 1454.705833 C65H115O33P
Gangliosides LMSP0601DC06
  • Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262577 1454.922488 C73H134N2O26
Gangliosides LMSP0601DG06
  • GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • KDN-GM2(d18:1/26:0)
44262609 1454.922488 C73H134N2O26
Gangliosides LMSP0601CI04
  • GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
52931292 1455.881352 C71H129N3O27
Diacylglycerophosphoinositolglycans LMGP15010148
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(16:0/16:1(9Z))
126457516 1456.721483 C65H117O33P
Diacylglycerophosphoinositolglycans LMGP15010164
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(18:1(9Z)/14:0)
126457532 1456.721483 C65H117O33P
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AI04
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260551 1456.901753 C72H132N2O27
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AC04
  • Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • Lewis a(d18:1/22:0)
44260631 1456.901753 C72H132N2O27
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AD04
  • Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • type I H antigen(d18:1/22:0)
44260639 1456.901753 C72H132N2O27
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AB04
  • Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • Lex-5(d18:1/22:0)
44260983 1456.901753 C72H132N2O27
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AD04
  • Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • type II antigen(d18:1/22:0)
44260999 1456.901753 C72H132N2O27
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AV04
  • Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261607 1456.901753 C72H132N2O27
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC02
  • Forssman antigen(d18:1/18:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260181 1457.860617 C70H127N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AD02
  • GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • Para-Forssman x3b(d18:1/18:0)
44260189 1457.860617 C70H127N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BC02
  • GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260389 1457.860617 C70H127N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BD02
  • GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260397 1457.860617 C70H127N3O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AC02
  • GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260501 1457.860617 C70H127N3O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AE02
  • GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260517 1457.860617 C70H127N3O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AO02
  • GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260597 1457.860617 C70H127N3O28
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AJ02
  • GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260685 1457.860617 C70H127N3O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AK02
  • GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • nLc5Cer(d18:1/18:0)
44261053 1457.860617 C70H127N3O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BN02
  • GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • P antigen(d18:1/18:0)
44261285 1457.860617 C70H127N3O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CE02
  • GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261421 1457.860617 C70H127N3O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AD02
  • Forssman-like iGb4(d18:1/18:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261861 1457.860617 C70H127N3O28

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024